🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 98422T100
- Market Cap
- Small Cap
- IPO
- 10/22/2021 · $16.00/share
Business: Xilio Therapeutics is a clinical-stage biotechnology company discovering and developing masked immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments.
Company Contact
- CEO
- René Russo
- CFO
- Chris Frankenfield
- Headquarters
- 828 Winter Street, Suite 300, Waltham, MA 02451
- Phone
- 617-430-4680
- Investor Relations
- Myles Clouston · 617-430-4680 · investors@xiliotx.com